Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Transradial vs Transfemoral Group-Randomized Efficacy and Safety Trial for Cerebral Angiography

This study will compare the efficacy and safety of the transradial approach versus the transfemoral approach for performing full cerebral angiography. Participants will undergo cerebral angiography via one of the two approaches and will be followed up during and after the procedure. The primary endpoint of this study is to evaluate the success rate of completing full cerebral angiography (including superselective catheterization of bilateral common carotid arteries, subclavian arteries near the vertebral artery origin, and the aortic arch) via the transradial approach versus the transfemoral approach. During the study, the medical team will also document procedural details, incidence of complications, patient comfort, and related costs to comprehensively evaluate the clinical performance differences between the two approaches.

Participants needed: 2,473
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Gansu Provincial Maternal and Child Health Care HospitalUpdated: Apr 22, 2026
Eligibility criteria

Age > 18 years; [+2]

Positive right Allen's test/Barbeau test; femoral artery occlusion (for the TFA... [+9]

Status: Not yet recruiting

Prospective Registry of Acute Ischemic Stroke in Children Under 18 Years Old in China

This observational study aims to investigate the real-world effectiveness and safety of different treatment strategies for acute ischemic stroke (AIS) in Chinese children under 18 years of age. Its primary research question is: In real-world clinical practice, does endovascular therapy (e.g., stent retriever thrombectomy, aspiration thrombectomy) improve 90-day functional outcomes in pediatric AIS patients with acute anterior or posterior circulation large vessel occlusion? Children under 18 years of age receiving routine AIS diagnosis and treatment at approximately 25-35 study centers across China will undergo neurological function assessments, imaging examinations, and evaluations of growth, development, and psychosocial status at baseline, 24 hours post-procedure, 7 days post-procedure or at hospital discharge, and at 90 days and 6 months post-onset. Adverse events will also be documented.

Participants needed: 1,000
Trial details
Age: 28-18Biological sex: AllType: ObservationalSponsor: Gansu Provincial Maternal and Child Health Care HospitalUpdated: Apr 24, 2026
Eligibility criteria

Age >28 days and <18 years; [+5]

Lack of imaging examination or stroke diagnosed without imaging [+3]